CL2014002976A1 - Metodo de analisis de una muestra biologica de un sujeto con cancer utilizando biomarcadores tnf, ripk1, cxl10, ccl5, nfkbia, herc5, cdyl, stk39 y mapk14 para la terapia inhibitoria con iap. - Google Patents
Metodo de analisis de una muestra biologica de un sujeto con cancer utilizando biomarcadores tnf, ripk1, cxl10, ccl5, nfkbia, herc5, cdyl, stk39 y mapk14 para la terapia inhibitoria con iap.Info
- Publication number
- CL2014002976A1 CL2014002976A1 CL2014002976A CL2014002976A CL2014002976A1 CL 2014002976 A1 CL2014002976 A1 CL 2014002976A1 CL 2014002976 A CL2014002976 A CL 2014002976A CL 2014002976 A CL2014002976 A CL 2014002976A CL 2014002976 A1 CL2014002976 A1 CL 2014002976A1
- Authority
- CL
- Chile
- Prior art keywords
- cxl10
- cdyl
- stk39
- herc5
- ripk1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261642899P | 2012-05-04 | 2012-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2014002976A1 true CL2014002976A1 (es) | 2015-02-13 |
Family
ID=48407833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2014002976A CL2014002976A1 (es) | 2012-05-04 | 2014-11-03 | Metodo de analisis de una muestra biologica de un sujeto con cancer utilizando biomarcadores tnf, ripk1, cxl10, ccl5, nfkbia, herc5, cdyl, stk39 y mapk14 para la terapia inhibitoria con iap. |
Country Status (20)
Country | Link |
---|---|
US (1) | US9353419B2 (es) |
EP (1) | EP2844764B1 (es) |
JP (1) | JP6513019B2 (es) |
KR (1) | KR20150011822A (es) |
CN (1) | CN104284988A (es) |
AU (1) | AU2013256182A1 (es) |
BR (1) | BR112014027413A2 (es) |
CA (1) | CA2871995A1 (es) |
CL (1) | CL2014002976A1 (es) |
ES (1) | ES2593046T3 (es) |
HK (1) | HK1202589A1 (es) |
IL (1) | IL235315A0 (es) |
MA (1) | MA37475A1 (es) |
MX (1) | MX2014013429A (es) |
PH (1) | PH12014502461A1 (es) |
RU (1) | RU2014148779A (es) |
SG (1) | SG11201406837TA (es) |
TN (1) | TN2014000443A1 (es) |
TW (1) | TW201347760A (es) |
WO (1) | WO2013166344A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015109391A1 (en) | 2014-01-24 | 2015-07-30 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Smc combination therapy for the treatment of cancer |
AR102981A1 (es) | 2014-12-11 | 2017-04-05 | Harvard College | Inhibidores de la necrosis celular y métodos de preparación de los mismos |
US11590197B2 (en) | 2017-11-01 | 2023-02-28 | The Regents Of The University Of California | Agents targeting inhibitor of apoptosis proteins |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
GB0215823D0 (en) | 2002-07-09 | 2002-08-14 | Astrazeneca Ab | Quinazoline derivatives |
DE60324964D1 (de) | 2002-07-15 | 2009-01-08 | Univ Princeton | Iap-bindende verbindungen |
AU2005206929B2 (en) | 2004-01-16 | 2008-01-24 | The Regents Of The University Of Michigan | Conformationally constrained Smac mimetics and the uses thereof |
CA2553871A1 (en) | 2004-01-16 | 2005-08-04 | The Regents Of The University Of Michigan | Smac peptidomimetics and the uses thereof |
EP1740173A4 (en) | 2004-03-23 | 2009-05-27 | Genentech Inc | AZABICYCLOOCTAN IAP INHIBITORS |
TWI417092B (zh) | 2004-04-07 | 2013-12-01 | Novartis Ag | Iap抑制劑 |
AU2005270104A1 (en) | 2004-07-02 | 2006-02-09 | Genentech, Inc. | Inhibitors of IAP |
US7674787B2 (en) | 2004-07-09 | 2010-03-09 | The Regents Of The University Of Michigan | Conformationally constrained Smac mimetics and the uses thereof |
US20100190688A1 (en) | 2004-07-12 | 2010-07-29 | Bin Chao | Tetrapeptide analogs |
WO2006020060A2 (en) | 2004-07-15 | 2006-02-23 | Tetralogic Pharmaceuticals Corporation | Iap binding compounds |
DK1836201T4 (da) | 2004-12-20 | 2013-11-11 | Genentech Inc | Pyrrolidininhibitorer af IAP. |
WO2007072225A2 (en) * | 2005-12-01 | 2007-06-28 | Medical Prognosis Institute | Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
CN101529254A (zh) * | 2006-10-19 | 2009-09-09 | 诺瓦提斯公司 | 有机化合物 |
EP2076778A2 (en) | 2006-10-19 | 2009-07-08 | Novartis AG | Organic compounds |
KR20100024923A (ko) | 2007-04-30 | 2010-03-08 | 제넨테크, 인크. | Iap의 억제제 |
US20120015352A1 (en) * | 2009-01-29 | 2012-01-19 | Otto-Von-Guericke-Universitat Magdeburg | Method of determining sensitivity of human or non-human animal cells to an iap antagonist |
IL313131A (en) * | 2009-02-11 | 2024-07-01 | Caris Mpi Inc | Molecular characterization of tumors |
CN102612651A (zh) * | 2009-09-18 | 2012-07-25 | 诺瓦提斯公司 | Iap抑制剂化合物的生物标志物 |
CN101956014B (zh) | 2010-09-30 | 2014-05-28 | 中山大学 | 一种用于鼻咽癌早期诊断的外周血7个基因标志物的检测试剂盒 |
-
2013
- 2013-05-03 MX MX2014013429A patent/MX2014013429A/es unknown
- 2013-05-03 RU RU2014148779A patent/RU2014148779A/ru not_active Application Discontinuation
- 2013-05-03 BR BR112014027413A patent/BR112014027413A2/pt not_active IP Right Cessation
- 2013-05-03 JP JP2015510469A patent/JP6513019B2/ja not_active Expired - Fee Related
- 2013-05-03 CA CA 2871995 patent/CA2871995A1/en not_active Abandoned
- 2013-05-03 AU AU2013256182A patent/AU2013256182A1/en not_active Abandoned
- 2013-05-03 MA MA37475A patent/MA37475A1/fr unknown
- 2013-05-03 ES ES13721886.3T patent/ES2593046T3/es active Active
- 2013-05-03 KR KR1020147033716A patent/KR20150011822A/ko not_active Application Discontinuation
- 2013-05-03 WO PCT/US2013/039362 patent/WO2013166344A1/en active Application Filing
- 2013-05-03 SG SG11201406837TA patent/SG11201406837TA/en unknown
- 2013-05-03 US US14/398,596 patent/US9353419B2/en not_active Expired - Fee Related
- 2013-05-03 CN CN201380022814.9A patent/CN104284988A/zh active Pending
- 2013-05-03 TW TW102115948A patent/TW201347760A/zh unknown
- 2013-05-03 EP EP13721886.3A patent/EP2844764B1/en active Active
-
2014
- 2014-10-21 TN TN2014000443A patent/TN2014000443A1/fr unknown
- 2014-10-23 IL IL235315A patent/IL235315A0/en unknown
- 2014-11-03 CL CL2014002976A patent/CL2014002976A1/es unknown
- 2014-11-04 PH PH12014502461A patent/PH12014502461A1/en unknown
-
2015
- 2015-03-20 HK HK15102857.1A patent/HK1202589A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20150105434A1 (en) | 2015-04-16 |
RU2014148779A (ru) | 2016-06-27 |
JP2015523056A (ja) | 2015-08-13 |
US9353419B2 (en) | 2016-05-31 |
TN2014000443A1 (en) | 2016-03-30 |
WO2013166344A1 (en) | 2013-11-07 |
MA37475A1 (fr) | 2016-05-31 |
EP2844764B1 (en) | 2016-06-22 |
TW201347760A (zh) | 2013-12-01 |
EP2844764A1 (en) | 2015-03-11 |
HK1202589A1 (zh) | 2015-10-02 |
KR20150011822A (ko) | 2015-02-02 |
MX2014013429A (es) | 2014-12-08 |
BR112014027413A2 (pt) | 2017-06-27 |
IL235315A0 (en) | 2014-12-31 |
PH12014502461A1 (en) | 2014-12-22 |
AU2013256182A1 (en) | 2014-11-13 |
CN104284988A (zh) | 2015-01-14 |
JP6513019B2 (ja) | 2019-05-15 |
ES2593046T3 (es) | 2016-12-05 |
CA2871995A1 (en) | 2013-11-07 |
SG11201406837TA (en) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255316A1 (zh) | 步驟簡化、小樣品、快速、易使用的生物/化學分析裝置和方法 | |
EP3345001A4 (en) | METHODS AND DEVICES FOR COLLECTION, EXTRACTION, CONCENTRATION, AND DETECTION OF ANALYTES FOR CLINICAL APPLICATIONS | |
EP3175247A4 (en) | Instrument for analyzing biological samples and reagents | |
EP3207499A4 (en) | Methods and systems for classifying biological samples, including optimization of analyses and use of correlation | |
EP3054285A4 (en) | Biochip for raman quantitative analysis of biological samples | |
HK1196984A1 (zh) | 實驗室樣品分配系統、實驗室系統及操作方法 | |
DK3080585T3 (da) | Biosensorer til biologisk eller kemisk analyse og fremgangsmåder til fremstilling heraf | |
WO2013107459A3 (en) | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples | |
WO2013066369A3 (en) | Methods for detecting graft-versus-host disease | |
EP2780465A4 (en) | METHOD, DEVICES AND KITS FOR OBTAINING AND ANALYZING CELLS | |
EP3216852A4 (en) | Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component | |
WO2011121454A3 (en) | Direct nucleic acid analysis | |
BR112013022735A2 (pt) | aparelho para processamento de uma amostra, aparelho para processamento de uma pluralidade de amostras, método para detectar a presença ou ausência de um analito em uma amostra e método para detectar a presença ou ausência de um analito em uma pluralidade de amostras | |
MX349011B (es) | Biomarcadores para terapia de inhibidor de hedgehog. | |
GB201219137D0 (en) | Direct nucleic acid amplification kit, reagent and method | |
EP3176268A4 (en) | Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereof | |
MX2015012319A (es) | Sistemas de instrumento analitico. | |
EP2672270A4 (en) | Specimen analysis system, specimen analysis device, and specimen analysis method | |
GB2496557A (en) | Products and methods for identifying rock samples | |
EP3166726A4 (en) | Devices and kits for collection, storage and analysis of samples and methods of production and use thereof | |
EP2891714A4 (en) | METHOD FOR THE ANALYSIS OF TARGET NUCLEIC ACID, KIT AND ANALYSIS DEVICE | |
EP3361251A4 (en) | METHOD FOR DETECTION OF CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE IN CANCER CELLS, AND COMPOSITION FOR TREATING CANCER | |
WO2012135749A3 (en) | Biomarkers for predicting sensitivity to cancer treatments | |
EP3450963A4 (en) | FLUORESCENCE PROBE, FLUORESCENCE DETECTION METHOD AND METHOD FOR USING A FLUORESCENCE PROBE | |
EP3555311A4 (en) | DETERMINATION OF A PHYSIOLOGICAL STATE IN A PERSON BY ANALYSIS OF CELL-FREE DNA FRAGMENT END POINTS IN A BIOLOGICAL SAMPLE |